Rice-Made blood protein under Real-World watch for emergency patients
NCT ID NCT07435922
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will follow about 2,000 patients who need urgent treatment for low blood protein (hypoalbuminemia) or low blood volume (hypovolemia) and are receiving a plant-based human albumin. Researchers will track side effects and how well the treatment restores albumin levels and blood volume. The goal is to gather real-world safety and effectiveness data, not to test a new drug.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOALBUMINEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hebei medical university third hosipital
Shijiazhuang, Hebei, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Urine test after a single dose of furosemide may spot kidney danger in ICU patients
- New wearable sensor could spot dehydration in seniors
- Fluid bolus study reveals how IV fluids impact heart and brain in low blood volume
- Silent threat: low albumin levels linked to worse outcomes in elderly cancer surgery
- Ultrasound test may help doctors avoid giving too much fluid to sick children
- Can tilting the bed improve pain detection in surgery?